2025-10-24 - Analysis Report
Okay, here's an analysis of Nike (NKE) based on the provided data, structured as requested.

## Nike (NKE) Stock Analysis

**Company Overview:** Nike Inc. is a global athletic footwear and apparel company.

### 1.  Performance vs. S&P 500 (VOO)

*   **NKE Cumulative Return:** -17.34%
*   **VOO Cumulative Return:** 99.09%
*   **Absolute Divergence:** -115.6 (NKE is significantly underperforming VOO)
*   **Relative Divergence:** 2.7 (Indicates NKE's underperformance is near the lower end of its historical divergence range with VOO).

**Analysis:** Nike has drastically underperformed the S&P 500. The relative divergence suggests this underperformance is historically significant but also at the extreme end, implying potential for reversion to the mean.

**Alpha, Beta Analysis Table:**

| Year       | CAGR    | MDD      | Alpha   | Beta   | Cap(B) |
| ---------- | ------- | -------- | ------- | ------ | ------ |
| 2015-2017  | 17.0%   | 77.7%    | -11.0%  | 0.1    | 94.2   |
| 2016-2018  | 0.0%    | 10.7%    | -16.0%  | -0.0   | 111.7  |
| 2017-2019  | 49.0%   | 69.4%    | 27.0%   | 0.4    | 152.7  |
| 2018-2020  | 45.0%   | 81.7%    | 22.0%   | 0.4    | 213.2  |
| 2019-2021  | 60.0%   | 81.7%    | 13.0%   | 0.8    | 251.1  |
| 2020-2022  | -11.0%  | 81.7%    | -10.0%  | 1.8    | 176.3  |
| 2021-2023  | -27.0%  | 80.6%    | -29.0%  | 2.4    | 163.6  |
| 2022-2024  | -71.0%  | 80.6%    | -91.0%  | 2.4    | 114.0  |
| 2023-2025  | -52.0%  | 83.6%    | -115.0% | -0.7   | 103.0  |

**Analysis:**

*   **CAGR:**  Shows strong growth in earlier periods, but significant negative growth in recent years.
*   **MDD:** Consistently high Maximum Drawdown values indicate substantial risk and volatility.
*   **Alpha:**  Generally negative alpha, especially in recent periods, suggests Nike has underperformed its benchmark.
*   **Beta:**  Increasing beta values in some periods (2020-2024) imply increasing correlation with the market and greater volatility.  The recent negative Beta (2023-2025) is unusual and may indicate a period where Nike is moving inversely to the broader market or is simply uncorrelated.
*   **Cap(B):** Market Cap declined significantly in recent years.

### 2. Recent Stock Price Movement

*   **Current Price:** 68.36
*   **Last Market Data:** Price: 69.68, Previous Close: 69.08, Change: 0.87 (Recent positive momentum)
*   **5-day Moving Average:** 67.73
*   **20-day Moving Average:** 69.136
*   **60-day Moving Average:** 73.3365

**Analysis:**

*   The stock price is below its 20-day and 60-day moving averages, suggesting a downtrend.  However, it's above the 5-day moving average, indicating some short-term positive momentum.
*   The recent positive change in the last market data confirms the immediate upward price action.

### 3.  Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended) - This is contradictory to other indicators suggesting caution.
*   **RSI:** 32.26 (Approaching oversold territory, potentially indicating a buying opportunity).
*   **PPO:** 0.0801 (Positive, indicating short term buying momentum)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (1 shares - Very Safe - MRI:0.90) (Cash Ratio: 0% on 2025-10-03).
*   **Recent (20-day) Relative Divergence Change:** -0.5 (Short-term decline).
*   **Expected Return (%):** -1154.5% (Very negative, suggesting significant underperformance vs. S&P 500 over a 2+ year investment horizon).

**Analysis:**

*   The high MRI is an outlier compared to other indicators.
*   The RSI suggests the stock is nearing oversold conditions, potentially attracting buyers.
*   The deeply negative expected return is concerning and highlights the challenges Nike faces.
*   The recent positive price change (0.87) likely reflects short term volatility.

### 4. Recent News & Significant Events (Yahoo Finance)

*   **Innovation Focus:** Articles highlight Nike's focus on innovation, including lab-developed technologies and motorized shoes.
*   **Partnerships:** The NIKE-SKIMS partnership is seen as a potential growth driver.
*   **Analyst Attention:**  Nike is attracting investor attention, with discussions of its performance relative to competitors.

**Analysis:**

*   The news suggests Nike is actively pursuing innovation and partnerships to revitalize growth.
*   Analyst interest indicates the market is closely watching Nike's turnaround efforts.

### 4-2. Analyst Opinions

*   **Consensus:** Buy (Mean: 2.02)
*   **Opinions:** 35 analysts
*   **Target Price:** Avg: 83.27 / High: 120.00 / Low: 38.00

**Analysis:**

*   Despite recent struggles, analysts generally maintain a "Buy" rating.
*   The average target price suggests potential upside from the current price.
*   The wide range between high and low target prices reflects uncertainty about Nike's future performance.

### 5. Recent Earnings Analysis

| 날짜         | EPS  | 매출      |
| ------------ | ---- | -------- |
| 2025-10-01   | 0.49 | 11.72 B$ |
| 2025-04-03   | 0.54 | 11.27 B$ |
| 2025-01-03   | 0.78 | 12.35 B$ |
| 2024-10-07   | 0.7  | 11.59 B$ |
| 2025-10-01   | 0.7  | 11.59 B$ |

**Analysis:**

*   Revenue has fluctuated.
*   Recent EPS figures (0.49) are lower than prior periods.

### 6. Financial Information

| Quarter      | Revenue   | Profit Margin |
| ------------ | --------- | ------------- |
| 2025-08-31   | $11.72B  | 42.18%        |
| 2025-05-31   | $11.10B  | 40.27%        |
| 2025-02-28   | $11.27B  | 41.49%        |
| 2024-11-30   | $12.35B  | 43.62%        |
| 2024-08-31   | $11.59B  | 45.36%        |

| Quarter      | Equity    | ROE      |
| ------------ | --------- | -------- |
| 2025-08-31   | $13.47B  | 5.40%    |
| 2025-05-31   | $13.21B  | 1.60%    |
| 2025-02-28   | $14.01B  | 5.67%    |
| 2024-11-30   | $14.04B  | 8.29%    |
| 2024-08-31   | $13.94B  | 7.54%    |

**Analysis:**

*   **Revenue:**  Fluctuating revenue indicates potential challenges in maintaining consistent growth.
*   **Profit Margin:** Declining profit margins suggest increased costs or pricing pressures.
*   **Equity:**  Equity has seen some decrease, implying potential capital deployment or shareholder returns.
*   **ROE:**  Decreasing ROE is a concern, indicating lower profitability relative to shareholder equity.

### 7. Overall Summary

Nike is facing significant challenges, including substantial underperformance compared to the S&P 500, declining profit margins, and a deeply negative expected return. While analyst consensus remains positive, and the company is pursuing innovation and partnerships, the financial data suggests caution. The MRI is an outlier and should be considered alongside other indicators. The approaching oversold RSI could present a short-term buying opportunity, but long-term investors should carefully consider the underlying financial trends.
